BSX
Boston Scientific Corporation · Healthcare · Medical - Devices
Señales de momentum (gestores comparables):
amplitud de titulares -4.2% ·
flujo de acciones +1.5% ·
nuevas posiciones netas -4.3%
· fórmula
Acumulación concentrada: acciones en aumento entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 7.31M | $317.13M | n/a | n/a |
| Q2 2026 | 180 | -1 | 1.05B | $45.33B | +3 | −5 |
| Q1 2026 | 185 | -2 | 1.08B | $67.75B | +2 | −5 |
| Q4 2025 | 186 | +1 | 1.13B | $107.60B | +2 | n/a |
| Q3 2025 | 28 | 0 | 719.46M | $70.18B | n/a | −1 |
| Q2 2025 | 26 | -1 | 668.30M | $71.71B | n/a | −1 |
| Q1 2025 | 24 | +1 | 275.71M | $27.75B | +1 | n/a |
| Q4 2024 | 23 | -1 | 268.54M | $23.93B | n/a | −1 |
| Q3 2024 | 23 | +2 | 200.54M | $16.75B | +2 | n/a |
| Q2 2024 | 21 | n/a | 195.84M | $15.04B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 63.96M | n/a | $5.71B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 36.93M | -2.4% | $3.30B | 2.6% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 36.17M | +10.2% | $3.23B | 0.6% | ▲ Add | 3 | SEC ↗ ×9 |
| 4 | Geode Capital Management ✦ (pasivo) | 30.63M | +3.5% | $2.73B | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Capital World Investors ✦ | 27.90M | +28.7% | $2.49B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 6 | Norges Bank ✦ (pasivo) | 19.73M | +3.4% | $1.76B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 8.95M | +8.4% | $799.09M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Marshall Wace ✦ | 8.87M | +7.6% | $791.90M | 1.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 9 | Millennium Management ✦ | 9.13M | -19.6% | $770.72M | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 10 | Fisher Asset Management ✦ | 5.80M | +21.6% | $518.14M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 5.59M | +9.5% | $499.47M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 4.93M | -49.6% | $440.48M | 0.4% | ▼ Trim | 3 | SEC ↗ ×2 |
| 13 | Adage Capital Partners ✦ | 2.62M | +0.7% | $234.05M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 2.25M | -33.6% | $200.59M | 0.6% | ▼ Trim | 3 | SEC ↗ |
| 15 | Viking Global Investors ✦ | 2.17M | +124.6% | $194.02M | 0.6% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 911.94K | -5.5% | $81.45M | 0.1% | ▼ Trim | 3 | SEC ↗ ×5 |
| 17 | D. E. Shaw & Co. ✦ | 763.50K | -56.5% | $68.20M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 18 | Two Sigma Investments ✦ | 741.85K | -35.7% | $66.26M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 162.91K | -54.3% | $14.55M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 129.32K | +7.5% | $11.55M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 21 | Soros Fund Management ✦ | 100.00K | -71.4% | $8.93M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 22 | Dodge & Cox ✦ | 94.80K | -0.5% | $8.47M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 11.43K | +43.7% | $1.02M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Renaissance Technologies | $21.62M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,653 tenedores, 1.31B acciones, $78.98B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Director · 2.04K acc. @ 49.22 · $100,408
Ventas en mercado abierto (S)
Sin ventas en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología